Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thai, U.S. Trade Meeting Set Over Compulsory License Policy

This article was originally published in PharmAsia News

Executive Summary

Thailand's Commerce Ministry permanent secretary scheduled a meeting with a U.S. Trade Representative official March 17 on the Asian nation's compulsory licensing policy on drug patents. The United States is to decide by the end of April whether to take Thailand off its Priority Watch List for countries that violate global intellectual property protection rules. Thai Commerce Minister Mingkwan Sangsuwan also is set to meet with USTR head Susan Schwab next month in Bangkok. Several Thai ministries are to decide this week on the status of the CL policy. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel